Clinigence Holdings Inc (NUTX)
NASDAQ:NUTX
Want to see NUTX full AI Analyst Report?
NUTX Stock Chart & Stats
$184.11
-$1.17(-3.51%)
At close: 4:00 PM EST
$184.11
-$1.17(-3.51%)
Day’s Range― - ―
52-Week Range$77.21 - $193.07
Previous CloseN/A
Volume3.28K
Average Volume (3M)174.95K
Market Cap
$818.26M
Enterprise Value$849.77M
Total Cash (Recent Filing)$207.35M
Total Debt (Recent Filing)$349.09M
Price to Earnings (P/E)3.4
Beta2.09
Next Earnings
Aug 06, 2026EPS Estimate
4.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)13.44
Shares Outstanding6,881,339
10 Day Avg. Volume109,608
30 Day Avg. Volume174,951
Financial Highlights & Ratios
PEG Ratio1.68
Price to Book (P/B)3.18
Price to Sales (P/S)1.20
P/FCF Ratio4.26
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue0.97
Enterprise Value/Gross Profit2.03
Enterprise Value/Ebitda2.91
Forecast
1Y Price Target
$237.50Price Target Upside29.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)15.41
Revenue Forecast (FY)$883.02M
Bulls Say, Bears Say
Bulls Say
Expansion PlansNutex reopened a micro-hospital in Red River, Texas, and plans to open 5-6 additional de novo micro-hospitals by the end of 2026.
Financial StabilityNutex has sufficient capital to maintain current operations and advance expansion plans, with cash of $96.4M and debt of $35.5M as of June 30, 2025.
Revenue GrowthNutex Health Inc. reported revenue and GAAP EPS significantly above consensus and estimates, with revenue up 240%.
Bears Say
Accounting IssuesNutex filed an NT 10-Q notification of inability to timely file its 10-Q due to the incorrect accounting classification of certain non-cash obligations, leading to the need for restatements.
Legal ChallengesPotential headwinds to NUTX's stock price include accounting restatements, arbitration dynamics, and lawsuits against Nutex's primary arbitration vendor, HaloMD.
Clinigence Holdings News
NUTX FAQ
What was Clinigence Holdings Inc’s price range in the past 12 months?
Clinigence Holdings Inc lowest stock price was $77.21 and its highest was $193.07 in the past 12 months.
What is Clinigence Holdings Inc’s market cap?
Clinigence Holdings Inc’s market cap is $818.26M.
When is Clinigence Holdings Inc’s upcoming earnings report date?
Clinigence Holdings Inc’s upcoming earnings report date is Aug 06, 2026 which is in 74 days.
How were Clinigence Holdings Inc’s earnings last quarter?
Clinigence Holdings Inc released its earnings results on Apr 30, 2026. The company reported $6.52 earnings per share for the quarter, beating the consensus estimate of $3.993 by $2.527.
Is Clinigence Holdings Inc overvalued?
According to Wall Street analysts Clinigence Holdings Inc’s price is currently Undervalued.
Does Clinigence Holdings Inc pay dividends?
Clinigence Holdings Inc does not currently pay dividends.
What is Clinigence Holdings Inc’s EPS estimate?
Clinigence Holdings Inc’s EPS estimate is 4.64.
How many shares outstanding does Clinigence Holdings Inc have?
Clinigence Holdings Inc has 6,881,339 shares outstanding.
What happened to Clinigence Holdings Inc’s price movement after its last earnings report?
Clinigence Holdings Inc reported an EPS of $6.52 in its last earnings report, beating expectations of $3.993. Following the earnings report the stock price went up 17.089%.
Which hedge fund is a major shareholder of Clinigence Holdings Inc?
Currently, no hedge funds are holding shares in NUTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clinigence Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$237.50 (29.00% Upside)
$237.50 (29.00% Upside)
Blogger Sentiment
Bullish
NUTX Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 21.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $45.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-26.53%
12-Months-Change
Fundamentals
Return on Equity
31.39%
Trailing 12-Months
Asset Growth
25.65%
Trailing 12-Months
Company Description
Clinigence Holdings Inc
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
NUTX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: operationally and strategically Nutex demonstrates strong liquidity, improved net income, positive cash flow, active share repurchases, patient satisfaction, and a clear strategy to internalize development and scale population health. However, significant margin pressure and a 21% drop in adjusted EBITDA driven by higher facility costs and timing effects from IDR/arbitration recognition temper the results. Same-hospital revenue growth was minimal and accounts receivable rose, highlighting near-term execution and working capital considerations. Regulatory and arbitration accounting dynamics introduce additional volatility. Overall, positive cash generation and strategic initiatives are balanced by meaningful margin and accounting headwinds.View all NUTX earnings summariesNUTX Stock 12 Month Forecast
Average Price Target
$237.50
▲(29.00% Upside)
Technical Analysis
HealthStream
―
Evolent Health
―
Health Catalyst
―
10x Genomics
―
Definitive Healthcare Corp
―
Ownership Overview
31.73% Insiders
6.01% Mutual Funds
11.89% Other Institutional Investors
37.81% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---